Highlights
NASDAQ: KNSA       Kiniksa Pharmaceuticals Ltd
Last Price Today's Change   Day's Range   Trading Volume
14.62   -0.31 (2.08%)  14.39 - 15.30  180,100

Overview

 
Avg Volume (4 weeks):309,966
4 Weeks Range:10.70 - 15.984
4 Weeks Price Volatility (%):
74.19%
52 Weeks Range:5.01 - 23.041
52 Weeks Price Volatility (%):
53.30%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Kiniksa Pharmaceuticals Ltd is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutic medicines for patients suffering from debilitating diseases.Its clinical-stage product candidates include Rilonacept, which is in Phase II clinical trials for the treatment of recurrent pericarditis, a debilitating inflammatory cardiovascular disease; Mavrilimumab, a monoclonal antibody for the treatment of giant cell arteritis; and KPL-716, KPL-045, KPL-404 are other monoclonal antibodies.

  Be the first to like this.
 


 

1843  6298  540  225 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 VXX 14.24+0.75 
 EEM 44.60-0.36 
 SPY 328.77-2.95 
 INTC 68.47+5.15 
 AMD 50.35-1.36 
 CHK 0.558-0.015 
 F 9.00-0.14 
 NIO 4.66-0.26 
 AVP 5.60-0.05 
 GE 11.71-0.06 
Partners & Brokers